Cherilyn Boller, M.S.
Executive Director, Program Strategy
Cherilyn Boller has more than 20 years of clinical research experience, with a focus on neuroscience for the last 15 years. She has provided oversight and full management support for Phase 1 through Phase 4 clinical studies and is responsible for providing strategic planning, risk mitigation, and project delivery expertise as well as operational advice for consultative services within neuroscience.
Ms. Boller’s career began as a staff chemist in drug discovery at a large pharmaceutical company, then transitioned to in-house clinical development where she worked on two drug candidates that resulted in FDA approval. Her career advanced from clinical coordinator at University of Texas Medical Branch, to a clinical scientist at a medical device company specializing in epilepsy and treatment resistant depression. She worked extensively in medical writing, clinical monitoring, and data management and also served as a safety officer. Ms. Boller joined Premier Research in 2008 and has extensive experience in neuroscience, but also in metabolic disorders, women’s health, and general medicine. She has led multiple global programs including schizophrenia, bipolar mania, depression, Alzheimer’s disease, and epilepsy.
Ms. Boller earned a Master’s Degree in organic chemistry from the University of Wisconsin-Madison. She has dual Bachelor’s degrees in chemistry and nursing from Widener University in Chester, PA; she was the valedictorian of the School of Nursing.